Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Antoni Torres

Showing results (411-420 of 794) with videos related to

Pageof 80
Sort By:
Frontiers in Medicine|October 17, 2022
Cytokine levels as predictors of mortality in critically ill patients with severe COVID-19 pneumonia: Case-control study nested within a cohort in ColombiaFrancisco José Molina, Luz Elena Botero, Juan Pablo Isaza, et al.
Archivos De Bronconeumologia|October 11, 2021
[Evaluation of Respiratory Sequelae in Patients With COVID-19, Where we are and Where we are Going. CIBERESUCICOVID and RECOVID Studies to Compare Patients Admitted to ICU vs Conventional Ward]Rosario Menéndez, Adrián Ceccato, Ignacio Martín-Loeches, et al.
Plos One|June 16, 2017
Treatment with macrolides and glucocorticosteroids in severe community-acquired pneumonia: A post-hoc exploratory analysis of a randomized controlled trialAdrian Ceccato, Catia Cilloniz, Otavio T Ranzani, et al.
The Journal of Infection|December 8, 2009
Validation and comparison of SCAP as a predictive score for identifying low-risk patients in community-acquired pneumoniaPedro P España, Alberto Capelastegui, José M Quintana, et al.
The Journal of Antimicrobial Chemotherapy|September 13, 2023
Efficacy and safety of ceftazidime/avibactam in patients with infections caused by β-lactamase-producing Gram-negative pathogens: a pooled analysis from the Phase 3 clinical trial programmeAntoni Torres, Michele Wible, Margaret Tawadrous, et al.
Journal of Clinical Medicine|January 23, 2020
Can Artificial Intelligence Improve the Management of PneumoniaMariana Chumbita, Catia Cillóniz, Pedro Puerta-Alcalde, et al.
Chest|May 17, 2007
Pneumonia severity index class v patients with community-acquired pneumonia: characteristics, outcomes, and value of severity scoresMauricio Valencia, Joan R Badia, Manuela Cavalcanti, et al.
The Journal of Antimicrobial Chemotherapy|February 13, 2016
Piperacillin population pharmacokinetics in critically ill patients with multiple organ dysfunction syndrome receiving continuous venovenous haemodiafiltration: effect of type of dialysis membrane on dosing requirementsMarta Ulldemolins, Ignacio Martín-Loeches, Mireia Llauradó-Serra, et al.
Clinicoeconomics and Outcomes Research : CEOR|March 25, 2022
Ceftaroline Fosamil for the Empiric Treatment of Hospitalized Adults with cSSTI: An Economic Analysis from the Perspective of the Spanish National Health SystemAntoni Torres, Alex Soriano, Simone Rivolo, et al.
Intensive Care Medicine|October 7, 2016
Increased incidence of co-infection in critically ill patients with influenzaIgnacio Martin-Loeches, Marcus J Schultz, Jean-Louis Vincent, et al.
Pageof 80

Showing results (411-420 of 794) with videos related to

Sort By:
Pageof 80
Frontiers in Medicine|October 17, 2022
Cytokine levels as predictors of mortality in critically ill patients with severe COVID-19 pneumonia: Case-control study nested within a cohort in ColombiaFrancisco José Molina, Luz Elena Botero, Juan Pablo Isaza, et al.
Archivos De Bronconeumologia|October 11, 2021
[Evaluation of Respiratory Sequelae in Patients With COVID-19, Where we are and Where we are Going. CIBERESUCICOVID and RECOVID Studies to Compare Patients Admitted to ICU vs Conventional Ward]Rosario Menéndez, Adrián Ceccato, Ignacio Martín-Loeches, et al.
Plos One|June 16, 2017
Treatment with macrolides and glucocorticosteroids in severe community-acquired pneumonia: A post-hoc exploratory analysis of a randomized controlled trialAdrian Ceccato, Catia Cilloniz, Otavio T Ranzani, et al.
The Journal of Infection|December 8, 2009
Validation and comparison of SCAP as a predictive score for identifying low-risk patients in community-acquired pneumoniaPedro P España, Alberto Capelastegui, José M Quintana, et al.
The Journal of Antimicrobial Chemotherapy|September 13, 2023
Efficacy and safety of ceftazidime/avibactam in patients with infections caused by β-lactamase-producing Gram-negative pathogens: a pooled analysis from the Phase 3 clinical trial programmeAntoni Torres, Michele Wible, Margaret Tawadrous, et al.
Journal of Clinical Medicine|January 23, 2020
Can Artificial Intelligence Improve the Management of PneumoniaMariana Chumbita, Catia Cillóniz, Pedro Puerta-Alcalde, et al.
Chest|May 17, 2007
Pneumonia severity index class v patients with community-acquired pneumonia: characteristics, outcomes, and value of severity scoresMauricio Valencia, Joan R Badia, Manuela Cavalcanti, et al.
The Journal of Antimicrobial Chemotherapy|February 13, 2016
Piperacillin population pharmacokinetics in critically ill patients with multiple organ dysfunction syndrome receiving continuous venovenous haemodiafiltration: effect of type of dialysis membrane on dosing requirementsMarta Ulldemolins, Ignacio Martín-Loeches, Mireia Llauradó-Serra, et al.
Clinicoeconomics and Outcomes Research : CEOR|March 25, 2022
Ceftaroline Fosamil for the Empiric Treatment of Hospitalized Adults with cSSTI: An Economic Analysis from the Perspective of the Spanish National Health SystemAntoni Torres, Alex Soriano, Simone Rivolo, et al.
Intensive Care Medicine|October 7, 2016
Increased incidence of co-infection in critically ill patients with influenzaIgnacio Martin-Loeches, Marcus J Schultz, Jean-Louis Vincent, et al.
Pageof 80